MD1180Z - Method for stimulating the formation of conditioned reflexes in the period of diminution of functions - Google Patents

Method for stimulating the formation of conditioned reflexes in the period of diminution of functions

Info

Publication number
MD1180Z
MD1180Z MDS20170030A MDS20170030A MD1180Z MD 1180 Z MD1180 Z MD 1180Z MD S20170030 A MDS20170030 A MD S20170030A MD S20170030 A MDS20170030 A MD S20170030A MD 1180 Z MD1180 Z MD 1180Z
Authority
MD
Moldova
Prior art keywords
formation
period
diminution
stimulating
functions
Prior art date
Application number
MDS20170030A
Other languages
Romanian (ro)
Russian (ru)
Inventor
Владимир ШЕПТИЦКИЙ
Юлия БЕРЕЗЮК
Светлана БУРЦЕВА
Original Assignee
Институт Физиологии И Санокреатологии Академии Наук Молдовы
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт Физиологии И Санокреатологии Академии Наук Молдовы filed Critical Институт Физиологии И Санокреатологии Академии Наук Молдовы
Priority to MDS20170030A priority Critical patent/MD1180Z/en
Publication of MD1180Y publication Critical patent/MD1180Y/en
Publication of MD1180Z publication Critical patent/MD1180Z/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The invention relates to experimental physiology, experimental medicine and pharmacology, in particular to methods for stimulating the formation of conditioned reflexes in the period of diminution of functions.According to the invention, the method comprises the administration as a food additive of Streptomyces fradiae CNMN-Ac-11 strain biomass metabolites, in a dose of 250 mg/kg body weight per day, for 90 days prior to the formation and in the period of formation of conditioned reflexes.
MDS20170030A 2017-03-02 2017-03-02 Method for stimulating the formation of conditioned reflexes in the period of diminution of functions MD1180Z (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20170030A MD1180Z (en) 2017-03-02 2017-03-02 Method for stimulating the formation of conditioned reflexes in the period of diminution of functions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20170030A MD1180Z (en) 2017-03-02 2017-03-02 Method for stimulating the formation of conditioned reflexes in the period of diminution of functions

Publications (2)

Publication Number Publication Date
MD1180Y MD1180Y (en) 2017-08-31
MD1180Z true MD1180Z (en) 2018-03-31

Family

ID=59759583

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20170030A MD1180Z (en) 2017-03-02 2017-03-02 Method for stimulating the formation of conditioned reflexes in the period of diminution of functions

Country Status (1)

Country Link
MD (1) MD1180Z (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1069631A3 (en) * 1980-07-02 1984-01-23 Эли Лилли Энд Компани (Фирма) Method for preparing tilactone and strain streptomyces fradiae nrrl 12188 for use in preparing tilactone
SU1645300A1 (en) * 1988-12-06 1991-04-30 Научно-Исследовательский Конструкторско-Технологический Институт Биологически Активных Веществ Streptomyces fradiae strain: producer of restrictase sfr 1

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1069631A3 (en) * 1980-07-02 1984-01-23 Эли Лилли Энд Компани (Фирма) Method for preparing tilactone and strain streptomyces fradiae nrrl 12188 for use in preparing tilactone
SU1645300A1 (en) * 1988-12-06 1991-04-30 Научно-Исследовательский Конструкторско-Технологический Институт Биологически Активных Веществ Streptomyces fradiae strain: producer of restrictase sfr 1

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Kim W.G. et al. Benzastatins H and I, new benzastatin derivatives with neuronal cell protecting activity from Streptomyces nitrosporeus. In: J. Antibiotics, 2001, vol. 54, р. 513-516 *
Shin-Ya K. et al. A novel neuronal cell protecting substance mescengricin produced by Streptomyces griseoflavus. In: J. Asian Natural Products Research, 2000, vol. 2, p. 121-132 *
Shin-Ya K. et al. Novel neuronal cell protecting substances, aestivophoenins A and B, produced by Streptomyces purpeofuscus. In: J. Antibiotics, 1995, vol. 48, is. 11, р. 1378-1381 *
Шептицкий В.А., Братухина А.А., Бурцева С.А. Условнорефлекторная деятельность белых крыс при длительном потреблении биопрепаратов на основе метаболитов Streptomyces massasporeus. In: Buletinul AŞM. Ştiinţele vieţii, 2007, nr. 2 (302), p. 7-12 *

Also Published As

Publication number Publication date
MD1180Y (en) 2017-08-31

Similar Documents

Publication Publication Date Title
NZ766454A (en) Composition and method for reducing chemotherapy-induced neutropenia via the administration of plinabulin and a g-csf agent
MX2017008813A (en) Beetle powder.
MX2019006207A (en) Polymorphic form of sepiapterin.
PH12017502379A1 (en) Drospirenone-based contraceptive for a female patient affected with excess weight
MX2016009231A (en) Administration of tasimelteon under fasted conditions.
WO2018230960A3 (en) Novel bifidobacterium bifidum strain and strain-derived polysaccharide
MX2019005040A (en) Methods and compositions for preventing vector-borne disease transmission.
NZ745187A (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
MX2021014523A (en) Methods of treating cholangiocarcinoma.
ZA201905212B (en) Rescue treatment of post operative nausea and vomiting
MD1180Z (en) Method for stimulating the formation of conditioned reflexes in the period of diminution of functions
PH12018502280A1 (en) Tetrahydropyran and thiopyran derivatives having multimodal activity against pain
AU2012377476A8 (en) Preparation and method for the prophylaxis and treatment of atypical osteoporosis
PH12020550104A1 (en) Salts of (r)-9-(2,5-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one
MY194024A (en) Use of cistanche tubulosa extract and isoacteoside in protection of muscles
PH12019502620A1 (en) 6h-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazepine derivative
WO2016072692A3 (en) Composition for preventing or treating mucositis comprising necrox as effective ingredient
MX2020008129A (en) Pharmaceutical composition comprising acylated derivative of human insulin analog and preparation method thereof.
MD3422G2 (en) Method of prophylaxis and treatment of gallinaceae knemidokoptosis
TW201613606A (en) Therapeutic drug for chronic renal failure
MX2020007062A (en) Cerdulatinib-containing topical skin pharmaceutical compositions and uses thereof.
MX2020014222A (en) Therapeutic methods using bacterial strains which are capable of increasing adenosine levels.
MX2022014158A (en) Methods that reduce food cravings, promote weight loss, and/or treat overweight or obesity.
Cowan Nausea, hepatitis and diarrhoea: 3 case reports
MX2018001528A (en) Pharmaceutical composition comprising sumatripan for treating migraine.

Legal Events

Date Code Title Description
FG9Y Short term patent issued
MK4Y Short term patent expired